Lv3
330 积分 2022-10-07 加入
Association of Driver Oncogene Variations With Outcomes in Patients With Locally Advanced Non–Small Cell Lung Cancer Treated With Chemoradiation and Consolidative Durvalumab
1个月前
已完结
Molecular Landscape and Therapeutic Strategies of Lung Cancer Lineage Plasticity
2个月前
已完结
EGFR Mutations and Lung Cancer
2个月前
已完结
Gumarontinib in patients with non-small-cell lung cancer harbouring MET exon 14 skipping mutations: a multicentre, single-arm, open-label, phase 1b/2 trial
2个月前
已完结
[Postoperative Recurrence of ROS1‒Positive Pulmonary Adenocarcinoma after 19 Years]
2个月前
已关闭
Evolving roles of MET as a therapeutic target in NSCLC and beyond
2个月前
已完结
Neoadjuvant PD-1 and PD-L1 Blockade With Chemotherapy for Borderline Resectable and Unresectable Stage III Non–Small Cell Lung Cancer
2个月前
已完结
First prototype checkpoint inhibitor B-cell epitope vaccine (PD1-Vaxx) en route to human Phase 1 clinical trial in Australia and USA: exploiting future novel synergistic vaccine combinations
2个月前
已完结
A Phase III Clinical Trial of the Epidermal Growth Factor Vaccine CIMAvax-EGF as Switch Maintenance Therapy in Advanced Non–Small Cell Lung Cancer Patients
2个月前
已完结
Tarlatamab for Patients with Previously Treated Small-Cell Lung Cancer
2个月前
已完结
皖公网安备34019202002308
